Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MESOBLAST LTD Capital/Financing Update 2017

Aug 24, 2017

31658_rns_2017-08-24_ee4c75ed-5d20-46af-a7e8-e20685820feb.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

MARKET RELEASE

25 August 2017

Mesoblast Limited

TRADING HALT

The securities of Mesoblast Limited (the “Company”) will be placed in Trading Halt Session State at the request of the Company, pending the release of an announcement by the Company. Unless ASX decides otherwise, the securities will remain in Trading Halt Session State until the earlier of the commencement of normal trading on Tuesday, 29 August 2017 or when the announcement is released to the market.

Security Code: MSB

Cheng Tang SENIOR ADVISER, LISTINGS COMPLIANCE (MELBOURNE)

ASX Compliance Pty Limited ABN 26 087 780 489

20 Bridge Street Sydney NSW 2000

www.asx.com.au Customer service 13 12 79

==> picture [253 x 50] intentionally omitted <==

25 August 2017

Cheng Tang

Senior Advisor, Listings Compliance

ASX Compliance Pty Ltd

Level 4, North Tower, Rialto Towers

MELBOURNE VIC 3000

By email: [email protected]

Dear Cheng

Mesoblast Limited (ASX: MSB) - Request for Trading Halt

Pursuant to Listing Rule 17.1, Mesoblast Limited ( Mesoblast ) requests that a trading halt be granted by the ASX in its ordinary shares effective immediately. For this purpose, Mesoblast provides the following information:

  • a) Mesoblast is seeking the trading halt pending an announcement to the ASX by Mesoblast regarding a fully underwritten capital raising comprising an accelerated non-renounceable entitlement offer of ordinary shares on a pro rata basis to existing eligible shareholders ( Entitlement Offer );

  • b) Mesoblast requests that the trading halt last until the earlier of either Mesoblast making an announcement to the market regarding completion of the institutional component of the Entitlement Offer or the commencement of trading on 29 August 2017; and

  • c) Mesoblast is not aware of any reason why the trading halt should not be granted.

  • If you have any queries in relation to the above, please do not hesitate to contact me.

Yours sincerely,

==> picture [123 x 48] intentionally omitted <==

Charlie Harrison

Company Secretary Mesoblast Limited